Horizon Therapeutics (NASDAQ: HZNP) plunged over 18% Wednesday after the company reported earnings, missing analyst profit and revenue estimates. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE